Annals of Oncology

News:

Safety of human research participants
Ann Oncol 13: 1837-1838; doi:10.1093/annonc/mdf352
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Editorial:

G. Paganelli, A. Luini, and U. Veronesi

Radioguided occult lesion localization (ROLL) in breast cancer: maximizing efficacy, minimizing mutilation
Ann Oncol 13: 1839-1840; doi:10.1093/annonc/mdf343
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Review:

Y. Xu and M. A. Villalona-Calero

Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
Ann Oncol 13: 1841-1851; doi:10.1093/annonc/mdf337
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Lung cancer:

P. J. Souquet, E. H. Tan, J. Rodrigues Pereira, R. Van Klaveren, A. Price, U. Gatzemeier, M. Jaworski, J. P. Burillon, and D. Aubert

GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine–cisplatin with vinorelbine–ifosfamide–cisplatin in metastatic non-small-cell lung cancer patients
Ann Oncol 13: 1853-1861; doi:10.1093/annonc/mdf316
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

V. Lorusso, E. Crucitta, N. Panza, N. Silvestris, M. Guida, F. Carpagnano, S. Mancarella, D. Sambiasi, and M. De Lena

Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer
Ann Oncol 13: 1862-1867; doi:10.1093/annonc/mdf308
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

B. Glimelius, R. Ristamäki, M. Kjaer, P. Pfeiffer, T. Skovsgaard, K. M. Tveit, T. Linné, J. E. Frödin, B. Boussard, D. Oulid-Aïssa, and S. Pyrhönen

Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer
Ann Oncol 13: 1868-1873; doi:10.1093/annonc/mdf324
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

P. Comella, R. Casaretti, V. De Rosa, A. Avallone, F. Izzo, F. Fiore, L. Lapenta, and G. Comella

Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies
Ann Oncol 13: 1874-1881; doi:10.1093/annonc/mdf307
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. Aschele, D. Debernardis, R. Bandelloni, S. Cascinu, V. Catalano, P. Giordani, S. Barni, D. Turci, G. Drudi, S. Lonardi, L. Gallo, F. Maley, and S. Monfardini

Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil
Ann Oncol 13: 1882-1892; doi:10.1093/annonc/mdf327
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

T. W. Kim, Y. K. Kang, J. H. Ahn, H. M. Chang, J. H. Yook, S. T. Oh, B. S. Kim, and J. S. Lee

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer
Ann Oncol 13: 1893-1898; doi:10.1093/annonc/mdf323
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Breast cancer:

G. Palmieri, G. Palomba, A. Cossu, M. Pisano, M. F. Dedola, M. G. Sarobba, A. Farris, N. Olmeo, A. Contu, A. Pasca, M. P. Satta, I. Persico, A. A. Carboni, P. Cossu-Rocca, M. Contini, J. Mangion, M. R. Stratton, and F. Tanda

BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling
Ann Oncol 13: 1899-1907; doi:10.1093/annonc/mdf326
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

R. Zanotti, A. Trolese, A. Ambrosetti, G. Nadali, C. Visco, M. M. Ricetti, F. Benedetti, and G. Pizzolo

Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin’s lymphoma
Ann Oncol 13: 1908-1914; doi:10.1093/annonc/mdf333
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

P. Chiusolo, G. Reddiconto, I. Casorelli, L. Laurenti, F. Sorà, L. Mele, L. Annino, G. Leone, and S. Sica

Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate
Ann Oncol 13: 1915-1918; doi:10.1093/annonc/mdf322
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Melanoma:

H. Schmidt, S. Larsen, L. Bastholt, K. Fode, C. Rytter, and H. von der Maase

A phase II study of outpatient subcutaneous histamine dihydrochloride, interleukin-2 and interferon- in patients with metastatic melanoma
Ann Oncol 13: 1919-1924; doi:10.1093/annonc/mdf325
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

A. Awada, S. Giacchetti, B. Gerard, P. Eftekhary, C. Lucas, D. de Valeriola, M. G. Poullain, J. Soudon, C. Dosquet, M.-H. Brillanceau, B. Giroux, M. Marty, H. Bleiberg, F. Calvo, and M. Piccart

Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules
Ann Oncol 13: 1925-1934; doi:10.1093/annonc/mdf321
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Janinis, A. McTiernan, D. Driver, C. Mitchell, A. M. Cassoni, J. Pringle, A. Kilby, and J. S. Whelan

A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma
Ann Oncol 13: 1935-1944; doi:10.1093/annonc/mdf338
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Clinical cases:

G. Veronesi, L. Spaggiari, P. G. Solli, F. Leo, G. Villa, and U. Pastorino

Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma
Ann Oncol 13: 1945-1947; doi:10.1093/annonc/mdf310
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. Lowndes, A. Darby, G. Mead, and A. Lister

Stevens–Johnson syndrome after treatment with rituximab
Ann Oncol 13: 1948-1950; doi:10.1093/annonc/mdf350
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

M. A. Chung and B. Cady

Caution urged with repeat sentinel lymph node biopsies
Ann Oncol 13: 1951; doi:10.1093/annonc/mdf317
[Extract] [FREE Full Text] [PDF] [Request Permissions]

G. Pinotti and B. Martinelli

A case of acute tubular necrosis due to oxaliplatin
Ann Oncol 13: 1951-1952; doi:10.1093/annonc/mdf311
[Extract] [FREE Full Text] [PDF] [Request Permissions]

L. Delval

Troponin I, cardiac ventricular dysfunction and causal toxicity of chemotherapy drugs
Ann Oncol 13: 1952-1953; doi:10.1093/annonc/mdf345
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. Cardinale

Reply to Letter to the Editor "Troponin I, cardiac ventricular dysfunction and causal toxicity of chemotherapy drugs", by L. Delval (Ann Oncol 2002; 13: 1952–1953)
Ann Oncol 13: 1953; doi:10.1093/annonc/mdf344
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. K. Whynes

The economic case for faecal occult blood screening
Ann Oncol 13: 1953-1955; doi:10.1093/annonc/mdf346
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

D. J. Kerr

N.B. La Thangue, L.R. Bandara (eds). Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins
Ann Oncol 13: 1957; doi:10.1093/annonc/mdf315
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. Hallek

B.D. Cheson (ed). Chronic Lymphoid Leukemias
Ann Oncol 13: 1957; doi:10.1093/annonc/mdf309
[Extract] [FREE Full Text] [PDF] [Request Permissions]

S. Mosconi

H. Bleiberg, N. Kemeny, P. Rougier, H. Wilke (eds). Colorectal Cancer: a Clinical Guide to Therapy
Ann Oncol 13: 1957-1958; doi:10.1093/annonc/mdf278
[Extract] [FREE Full Text] [PDF] [Request Permissions]

F. Boccardo

V.C. Jordan, B.J.A. Furr (eds). Hormone Therapy in Breast and Prostate Cancer
Ann Oncol 13: 1958-1959; doi:10.1093/annonc/mdf211
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Corrigenda:

G. M. Mead, M. R. Sydes, J. Walewski, A. Grigg, C. S. Hatton, P. Norbert, C. Guarnaccia, M. S. Lewis, J. McKendrick, S. P. Stenning, and D. Wright

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study Ann Oncol 2002; 13: 1264–1274
Ann Oncol 13: 1961; doi:10.1093/annonc/mdf353
[Extract] [FREE Full Text] [PDF] [Request Permissions]

P. Workman

The impact of genomic and proteomic technologies on the development of new cancer drugs Ann Oncol 2002; 13 (Suppl 4): 115–124
Ann Oncol 13: 1961; doi:10.1093/annonc/mdf354
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.